암 치료를 위한 PD-1 안타고니스트, ATR 억제제 및 백금화제의 조합

본 발명은 암의 치료에 유용한 조합 치료요법에 관한 것이다. 특히, 본 발명은 PD-1 안타고니스트, ATR 억제제 및 백금화제를 포함하는 치료 조합에 관한 것이다. The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises a PD-1 antagonist, an ATR inhibito...

Full description

Saved in:
Bibliographic Details
Main Authors FALK MARTIN, DAHMEN HEIKE, TADJALLI MEHR KEYVAN, ALIMZHANOV MARAT, SOULARD PATRICIA, ZENKE FRANK, SCHROEDER ANDREAS, ZIMMERMANN ASTRID
Format Patent
LanguageKorean
Published 07.06.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:본 발명은 암의 치료에 유용한 조합 치료요법에 관한 것이다. 특히, 본 발명은 PD-1 안타고니스트, ATR 억제제 및 백금화제를 포함하는 치료 조합에 관한 것이다. The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises a PD-1 antagonist, an ATR inhibitor and a platinating agent.
Bibliography:Application Number: KR20217011118